The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Metrics for External Model Evaluation with an Application to the Population Pharmacokinetics of Gliclazide
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gelman, A., Carlin, J. B., Stern, H. S., & Rubin, D. B. (2003) · doi:10.1201/9780429258480 · Cited by 27,276
An improved Bonferroni procedure for multiple tests of significance
SIMES, R. J. (1986) · Biometrika · doi:10.1093/biomet/73.3.751 · Cited by 2,396
Some suggestions for measuring predictive performance
Sheiner, L. B., & Beal, S. L. (1981) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01060893 · Cited by 1,617
Ways to Fit a PK Model with Some Data Below the Quantification Limit
Beal, S. L. (2001) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1023/a:1012299115260 · Cited by 1,114
A Linear Mixed-Effects Model with Heterogeneity in the Random-Effects Population
Verbeke, G., & Lesaffre, E. (1996) · Journal of the American Statistical Association · doi:10.1080/01621459.1996.10476679 · Cited by 594
Evaluating Pharmacokinetic/Pharmacodynamic Models Using the Posterior Predictive Check
Yano, Y., Beal, S. L., & Sheiner, L. B. (2001) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1023/a:1011555016423 · Cited by 407
Stability and Performance of a Population Pharmacokinetic Model
Ette, E. I. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04326.x · Cited by 353
Pharmacokinetic/Pharmacodynamic Modeling in Drug Development
Sheiner, L. B., & Steimer, J.-L. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.67 · Cited by 351
P Values for Composite Null Models
Bayarri, M. J., & Berger, J. O. (2000) · Journal of the American Statistical Association · doi:10.1080/01621459.2000.10474309 · Cited by 335
Holford, N. H. G., Kimko, H. C., Monteleone, J. P. R., & Peck, C. C. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.209 · Cited by 289
Asymptotic Distribution of P Values in Composite Null Models
Robins, J. M., van der Vaart, A., & Ventura, V. (2000) · Journal of the American Statistical Association · doi:10.1080/01621459.2000.10474310 · Cited by 176
Lesko, L. J., Rowland, M., Peck, C. C., & Blaschke, T. F. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/00912700022009530 · Cited by 152
Role of modelling and simulation in Phase I drug development
Aarons, L. J., Karlsson, M. O., Mentré, F., Rombout, F., Steimer, J., & Peer, A. V. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00096-3 · Cited by 133
Self-citationPrediction Discrepancies for the Evaluation of Nonlinear Mixed-Effects Models
Mentré, F., & Escolano, S. (2005) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-005-0016-4 · Cited by 120
Self-citationSimulation for Designing Clinical Trials
(2002) · CRC Press eBooks · doi:10.1201/9780203910276 · Cited by 99
Lesko, L. J., Rowland, M., Peck, C. C., & Blaschke, T. F. (2000) · Pharmaceutical Research · doi:10.1023/a:1007574217260 · Cited by 85
Taylor, J. M., & Law, N. J. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19981030)17:20<2313::aid-sim935>3.0.co;2-v · Cited by 71
Frey, N., Laveille, C., Paraire, M., Leblond‐Francillard, M., Holford, N. H. G., & Jochemsen, R. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01751.x · Cited by 63
Self-citationDelrat, P., Paraire, M., & Jochemsen, R. (2002) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.303 · Cited by 59
Population pharmacokinetics of tobramycin.
Aarons, L. J., Vožeh, S., Wenk, M., Weiss, P., & Folláth, F. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb05431.x · Cited by 56
Mesnil, F., Mentré, F., Dubruc, C., Thénot, J., & Mallet, A. (1998) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1023/a:1020505722924 · Cited by 33
Self-citationAsymptotic Distribution of P Values in Composite Null Models: Rejoinder
Robins, J. M. W., van der Vaart, A., & Ventura, V. (2000) · Journal of the American Statistical Association · doi:10.2307/2669757 · Cited by 17
Cited by
Karlsson, M. O., & Savic, R. M. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100241 · Cited by 541
Comets, E., Brendel, K., & Mentré, F. (2008) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2007.12.002 · Cited by 450
Self-citationModel Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics
Nguyen, T. H. T., Mouksassi, M., Holford, N., Al‐Huniti, N., Freedman, I., Hooker, A. C., John, J., Karlsson, M. O., Mould, D. R., Pérez Ruixo, J. J., et al. (2017) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12161 · Cited by 402
Self-citationPopulation pharmacokinetic analysis of infliximab in patients with ulcerative colitis
Fasanmade, A. A., Adedokun, O. J., Ford, J., Hernandez, D., Johanns, J., Hu, C., Davis, H. M., & Zhou, H. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0718-4 · Cited by 327
Simon, N., Castinetti, F., Ouliac, F., Lesavre, N., Brue, T., & Oliver, C. (2010) · Clinical Pharmacokinetics · doi:10.2165/11531290-000000000-00000 · Cited by 61
Metadata
- Authors
- Brendel, K., Comets, E., Laffont, C., Laveille, C., & Mentré, F.
- Venue
- Pharmaceutical Research
- Published
- 2006-08-12
- Volume
- 23
- Issue
- 9
- Pages
- 2036-2049
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W2120725688
- Cited by
- 307
- References
- 22
- FWCI
- 5.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.